Equitas Small Finance Bank Ltd IPO Message Board (Page 1)

Equitas small finance bank Customer care toll free helpline number +91-839-2064-051. Contact here for balance or any different enquiry.

Despite market rallying this stock is not performing. Equitas parent company is half the issue price. People should switchover to better stocks as can't expect returns from equitas small finance

SIR I apply for ipo equitas bank for 2lot of 450each but I get 630 and my money cut for 810share how did I get refund balance amt till 12nov my BAL amt not credit what to do

First time I was not sure about apply an IPO or not
First time I ignored the senior members view/advice
First time I applied without any emotion and view

In short, I bet on a lottery IPO, got allotment and now see how the bet goes further :)

Lottery nahi laggi but flop bhi nahi hui
Now see how it will go for longer run

Equitas SF bank is not a bad company, but the hanging sword of time to timeFPO/OFS of this share till next year will not allow this share to gain. The promoters should have reduced their holding as one go as per the RBI guidelines, this hanging sword will bring prices down only.

today it touched high of 33.15.
Gamble of making 1 application under SH quota is not that bad.
Hopefully it will turn green from tomorrow onwards due to high QIB demand

Aaj ESFB ki listing hue hai.
Forum mein itna sannata kyo hai bhai?

@techuser,

I totally know ESFB issue ruined IPO sentiments.

Gland Pharma IPO is coming in Diwali. I am finding Gland Pharma business very attractive.

It's a Indian company with Chinese promotors, but company business model is unique in India.

IPO size is big, so retailers will have good chance of allotment. Let admin open the page and ipo price band is declared. Then we can come to some conclusion

@Nandkishorji, Yeah agree with you.

In fact, it's not only ESFB, but the UTI (discount) and Mazagon (below expected even though HUGE subscription) listings are disappointing.

Gland Pharma seems to be quite big size ipo, 6000 crore, and thus good chances of allotment to retail. Again, as we've seen in past, whenever there's a sure shot allotment for retailers, there's nothing left on the table (latest ex: SBI Cards). Basically, no one wants retailers earn very easily.

So let's hope for the best in upcoming IPOs!

Admin Ji

Please open New Page for " Gland Pharma IPO "

Thank you.

Today Economic Times also reported 6000 Crore IPO of Gland Pharma next week

New page is open..

Hyderabad-based Gland Pharma’s Rs 6,000 crore initial public offer (IPO) is set to hit the market next week..

Listed in discount as per expectations...

Listing price below 30 rs. Just sell on listing as this stock will be available at less than half value which is 16 rs within 1 year.

As predicted listing will be below 30 rs with negative bias. Just sell on opening to avoid further loss.

Gland pharma ipo may come next week

Wish you all Happy Pre Diwali listing

Those who have purchased 1 share of equitas holding for applying in shareholders category ipo, should accumulate more 20-50 shares at current market price. Sell those shares @51-55 range to recover dp charges and other expenses. Company is going to get 237 Cr from ofs of ESFB. So it's balance sheet will be a bit stronger. So in long term parent company EQUITAS is a better bet than ESFB

@ Ankur sir, sorry if I have hurt your sentiment. There is a proverb - One shoe does not fit all. That's why I have given two options

1. Invest in long term because I can see only one good opportunity in equitas, rs 237 Cr coming from ofs. But, if market falls, equitas may bleed more. No one can guarantee you whether it will go up or down. That's why I have given another option

2. Also, you can purchase few shares of equitas on experiment basic and can exit the script later when you see some profit. Doing experiments with small amount gives your better experience in market. You will not end up with huge losses atleast.

There are other options but that are not very much significant like
3. Sell single share @48
4. Hold single share in portfolio and do nothing with it

Choice is yours, you can choose anyone.

Just like there is an upper ceiling on brokerage chargeable of 2.5%, Sebi should also make sure that DP charges of total sale value of shares below Rs 50 or 100, should have a DP charge of Rs 5 only.
25 shares of rcom bought at higher levels will not give you anything now after deducting DP charges

Surprised to hear about ASHOK LEYLANDs fantastic sale numbers during this festival month. No Covid effect?

Because PM put Railway into Coma.Taken oath and bribe to privatise all public assets.????
New railway IPOs are the only hopeful things left behind from indian railway.

I think passengers train were on halt, cargo train are running

Burger King India IPO – Schedule *(Tentative)*

??th Nov – Announcement of Price Band
??th Nov – Anchor Investors Allotment
??th Nov – Offer Opens
??th Nov – Offer Closes
??th Nov – Finalisation of Basis of Allotment
??th Nov – Unblocking of ASBA Accounts
??th Nov – Credit of Equity Shares to Depository Accounts
??th Nov – Commencement of Trading


Burger King India IPO – Issue Information *(Tentative)*

Issue Opens on: ?? November 2020
Issue Closes on: ?? November 2020
Issue Type: Book Built Issue IPO
Issue Size: 16,22,72,727 Shares
Face Value: Rs.10/- per Share
Issue Price: Rs.43 – Rs.44 per Share *(Tentative)*
Discount: NIL
Market Lot: 340 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 29,09,41,785 Shares
Fresh Issue of Shares 12,31,63,636 @44/- = Rs.541.92Crs
Offer for Sale of 6,00,00,000 Shares @44/- = Rs.264.00Crs
Less: Pre-IPO Placement of (2,08,90,909) Shares @44/- = Rs.(91.92)Crs
Equity Shares outstanding after the Issue = 16,22,72,727 Shares

Category-wise Break up:
Anchor – 7,30,22,727 Shares = 321.30Crs
QIB – 4,86,81,818 Shares = 214.20Crs
NII – 2,43,40,909 Shares = 107.10Crs
RII – 1,62,27,273 Shares = 71.40Crs (Lot size: 340 = 47,727 Forms)
Total Issue – 16,22,72,727 Shares = 714.00Crs.

Subscription required for 1X
RII = 47,727 Forms
NII = 107.10 Crs


Burger King India IPO – Financial Information (Basis of Valuation)

The information is collated from the following documents:
1) DRHP = Draft Red Herring Prospectus dated November 2, 2019 (320 pages)

EPS for FY16-17 >>> Rs.(04.87) (Page #77 of DRHP)
EPS for FY17-18 >>> Rs.(03.10) (Page #77 of DRHP)
EPS for FY18-19 >>> Rs.(01.44) (Page #77 of DRHP)
EPS for Q119-20 >>> Rs.(00.07) (Page #77 of DRHP)

RoNW for FY16-17 >>> (19.55)% (Page #78 of DRHP)
RoNW for FY17-18 >>> (28.64)% (Page #78 of DRHP)
RoNW for FY18-19 >>> (15.33)% (Page #78 of DRHP)
RoNW for FY19-20 >>> (00.71)% (Page #78 of DRHP)

NAV as on June 30, 2019 was Rs.9.30 (Page #78 of DRHP)

Listed Industry Peer Group (Page #87 of DRHP): Jubilant Foodworks, Westlife Development


Burger King India IPO – *Market’s Current Estimates of oversubscription*:

NII = 30K Crs. = ~280.11X
RII = 20L Forms = 41.90X Applic. wise (Avg allotment of ~8.11 shares per lot)

Interest cost *@7.00%p.a.* for 7days = 5.91paise for 1X

Thus, for NII the costing = 280.11 X 5.91paise = Rs.16.55 per share (= GMP)

And, for RII the costing = 8.11 X 16.55 = Rs.134/- (= Kostak)


Burger King India IPO – *GMP Estimated*
GMP 15 +/- 2
Kostak 125 +/- 25

How burger King will come in November. 2 weeks ago, it refiled drhp. Sebi generally takes 4 to 6 weeks in Happy scenario to approve offer draft. And after that merchant banker takes 2 weeks atleast to prepare for ipo. So it will not land in November defiantly.

Gland Pharma IPO – Schedule *(Tentative)*

??th Nov – Announcement of Price Band
??th Nov – Anchor Investors Allotment
??th Nov – Offer Opens
??th Nov – Offer Closes
??th Nov – Finalisation of Basis of Allotment
??th Nov – Unblocking of ASBA Accounts
??th Nov – Credit of Equity Shares to Depository Accounts
??th Nov – Commencement of Trading


Gland Pharma IPO – Issue Information *(Tentative)*

Issue Opens on: ?? November 2020
Issue Closes on: ?? November 2020
Issue Type: Book Built Issue IPO
Issue Size: 4,44,79,019 Shares
Face Value: Rs.1/- per Share
Issue Price: Rs.1,300 – Rs.1,300 per Share *(Tentative)*
Discount: NIL
Market Lot: 10 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 15,49,49,490 Shares
Fresh Issue of Shares 96,15,384 @1,300/- = Rs.1,250.00Crs
Offer for Sale of 3,48,63,635 Shares @1,300/- = Rs.4532.27Crs
Equity Shares outstanding after the Issue = 16,45,64,874 Shares

Category-wise Break up:
Anchor – 1,33,43,706 Shares = 1,734.68Crs
QIB – 88,95,804 Shares = 1,156.45Crs
NII – 66,71,853 Shares = 867.34Crs
RII – 1,55,67,656 Shares = 2,023.80Crs (Lot size: 10 = 15,56,766 Forms)
Total Issue – 4,44,79,019 Shares = 5,782.27Crs.

Subscription required for 1X
RII = 15,56,766 Forms
NII = 867.34 Crs


Gland Pharma IPO – Financial Information (Basis of Valuation)
The information is collated from the following documents:
1) DRHP = Draft Red Herring Prospectus dated July 10, 2020 (316 pages)

EPS for FY17-18 >>> Rs.20.73 (Page #86 of DRHP)
EPS for FY18-19 >>> Rs.29.16 (Page #86 of DRHP)
EPS for FY19-20 >>> Rs.49.88 (Page #86 of DRHP)

RoNW for FY17-18 >>> 13.32% (Page #87 of DRHP)
RoNW for FY18-19 >>> 15.79% (Page #87 of DRHP)
RoNW for FY19-20 >>> 21.20% (Page #87 of DRHP)

NAV as on March 31, 2020 was Rs.235.32 (Page #87 of DRHP)

Listed Industry Peer Group (Page #87 of DRHP): NONE

 
Gland Pharma IPO – *Market’s Current Estimates of oversubscription*:

NII = 40K Crs. = ~46.12X
RII = 25L Forms = 1.61X Applic. wise (Avg allotment of ~6.85 shares per lot)

Interest cost *@7.00%p.a.* for 7days = 174.52paise for 1X

Thus, for NII the costing = 46.12 X 174.52paise = Rs.80.49 per share (= GMP)

And, for RII the costing = 6.85 X 80.49 = Rs.551/- (= Kostak)


Gland Pharma IPO – *GMP Estimated*
GMP 80 +/- 2
Kostak 550 +/- 25

Ye share niche list hoga aur badmee itna bhagega 20% buyer circut lagegi.... agar 30 rs mee milta hai to lee lenaaaa. 36 ka buyer lagegahi.....

Don't mind...shubham ji..
Harit ji is ipo guru category..any message give us increase our knowledge..anyway if possible for our ipo guru,pls suggest best ipo share sell strategy for gain maximum on listings day..can we sell preopen or watch full day?.

@god ji, no strategy can be taken for granted.

The listing of Rossari biotech was around 660 at 10 am and the stock touched upper circuit of Rs 804 at around 2.30 pm.

Listing of mazagon-dock was at around 215 in preopen hours and later in afternoon it hit lower circuit of 172 and later it closed at 176.



So, one should do his own research and then decide when to sell. Actually there is no best strategy to sell shares on listing day to get maximum gain. It's a pure luck.

Aniket sir,
Have you sold Angel broking or still holding

Sold 2 lot @ 362. Kept one for a target of 400+
Thanks.